June 30 Merck & Co Inc said its drug for
treating chemotherapy-induced nausea and vomiting, Emend, was
shown to be more effective than a placebo in a late-stage trial
The company said 51 percent of patients getting Emend showed
no vomiting, no retching and no use of rescue medication for
nausea and vomiting 25 to 120 hours following the beginning of
chemotherapy, compared to 26 percent of those on a placebo.
The drug is already approved for treating
chemotherapy-induced nausea and vomiting in adults.
(Reporting by Esha Dey in Bangalore; Editing by Saumyadeb